WHITE BEAR LAKE, MINNESOTA — Envoy Medical Inc. (NASDAQ: COCH) announced that all 56 patients enrolled in its pivotal clinical trial of the investigational Acclaim® cochlear implant have completed their three-month follow-up visits.
The milestone follows